In the current study, we focused on examining the cytotoxicity of pan-HDAC inhibitor panobinostat against tumor cell lines both alone and in combination with NK cells, particularly to show its immunomodulatory potential on these tumor cell lines. Here, HDAC9 is linked to neoplasm.